Literature DB >> 6846255

Free erythrocyte protoporphyrin (FEP) I. Normal values for adults and evaluation of the hematofluorometer.

W L Marsh, D P Nelson, H M Koenig.   

Abstract

Since the early 1970s, measurement of free erythrocyte protoporphyrin (FEP) (by microextraction or by hematofluorometer) has been widely used to screen for lead poisoning and to evaluate microcytic red blood cell (RBC) disorders in children. However, published information on normal values for FEP, performance of the hematofluorometer, and usefulness of FEP in classifying microcytic RBC disorders in adults is scant. In an adult population with normal hematocrit and MCV and normal values for serum ferritin, blood lead level, and serum bilirubin, we obtained normal hematofluorometer FEP levels of less than 30 micrograms/dL for men, and less than 40 micrograms/dL levels for women. We have evaluated a hematofluorometer against a standard microextraction procedure and feel that the hematofluorometer is superior for clinical laboratories if elevated FEPs are confirmed by retesting with washed RBC. In the second part of this paper we demonstrate the usefulness of the FEP in classifying microcytic RBC disorders in adults.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6846255     DOI: 10.1093/ajcp/79.6.655

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Changing trends in the epidemiology of pediatric lead exposure: interrelationship of blood lead and ZPP concentrations and a comparison to the US population.

Authors:  Offie Porat Soldin; John C Pezzullo; Brian Hanak; Maureen Miller; Steven J Soldin
Journal:  Ther Drug Monit       Date:  2003-08       Impact factor: 3.681

2.  Pediatric reference ranges for zinc protoporphyrin.

Authors:  Offie Porat Soldin; Maureen Miller; Steven J Soldin
Journal:  Clin Biochem       Date:  2003-02       Impact factor: 3.281

3.  Relationship between blood Lead status and anemia in Ugandan children with malaria infection.

Authors:  Ambrose Mukisa; Denis Kasozi; Claire Aguttu; Peter C Vuzi; Joseph Kyambadde
Journal:  BMC Pediatr       Date:  2020-11-14       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.